INMED PHARMACEUTICALS INC
INM·457637601·UQ·Common Stock·Healthcare - Drug Manufacturers - Specialty & Generic-13D/G
INM institutional ownership changes in Q2 2026: 1 institution opened or added positions, 3 trimmed or exited. INM (INMED PHARMACEUTICALS INC) is held by 3 institutional investors as of Q2 2026. Top institutional shareholders: JANE STREET GROUP, LLC ($66,771), CITADEL ADVISORS LLC ($40,430), Federation des caisses Desjardins du Quebec ($4). Net institutional sentiment: Bearish.
Who's Trading
Source dates: Price Oct 28, 2026 · Insiders Oct 20, 2026 · Activists Apr 2, 2025 · Congress none
Top Holders
Continue exploring
Other Healthcare stocks held by institutions
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer